Circulating tumor cells (CTCs), originating from primary neoplastic tissues, infiltrate blood vessels, migrate through the bloodstream, and establish secondary tumor foci. The detection of CTCs holds ...

CTC are outnumbered by red blood cells and leukocytes in the blood. Stem cells and epithelial cells in the bone marrow are additional contaminants for DTC. Therefore, a first step aiming at enriching ...

Hepatocellular carcinoma (HCC) is a significant global health concern, particularly in regions like the Asia-Pacific, where chronic viral hepatitis and liver diseases contribute to its high incidence ...

We conducted a systematic meta-analysis of 30 studies involving 3,287 patients with postoperative NSCLC to evaluate the diagnostic performance of ctDNA-based MRD testing for recurrence detection and ...

Hippocampal Avoidance During Prophylactic Cranial Irradiation for Patients With Small Cell Lung Cancer: Randomized Phase II/III Trial NRG-CC003 We integrated data from five prospective studies of ...

Researchers developed a liquid biopsy method that improved detection of live circulating tumor cells in triple negative ...

– Highlights the use of Invitae's (NVTA) personalized cancer monitoring (PCM) technology to correlate clinical outcomes with minimal residual disease (MRD) presence – – The analysis demonstrates the ...

Glioblastoma (GBM) is an aggressive brain tumor characterized by marked intra- and inter-tumoral heterogeneity and inevitable recurrence. Although extracranial metastasis is rare, circulating tumor ...

An implantable scaffold and magnetic probes capture circulating tumor cells directly in the bloodstream, eliminating over 90% of captured cells in rabbits and goats.

Of all the types of breast cancer, triple negative breast cancer (TNBC) is the most aggressive and lacks specific therapies.